Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        121-130 of 152 results for 'PROTECT trial'

        Refine search

        News & Events

        Decades of bullying research pays off

        Professor Donna Cross and her team at the Telethon Kids Institute have challenged and overturned damaging attitudes that saw bullying tolerated in childhood. ...

        Research

        Safety, tolerability, and effect of a single aural dose of Dornase alfa at the time of ventilation tube surgery for otitis media: A Phase 1b double randomized control trial

        One third of children require repeat ventilation tube insertion (VTI) for otitis media. Disease recurrence is associated with persistent middle ear bacterial biofilms. With demonstration that Dornase alfa (a DNase) disrupts middle ear effusion biofilms ex vivo, we identified potential for this as an anti-biofilm therapy to prevent repeat VTI. First, safety and tolerability needed to be measured. ...

        Research

        Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children

        Combining elevated CRP with the presence or absence of clinical signs/ symptoms differentiates definite bacterial from presumed viral pneumonia better than CRP alone ...

        Research

        Determining the off-target effects of infant vaccines on respiratory infection outcomes in Western Australian children

        Christopher Hannah Lea-Ann Blyth Moore Kirkham CC HC LK MBBS (Hons) DCH FRACP FRCPA PhD OAM BSc (Hons) GradDipClinEpi PhD PhD Director, Wesfarmers ...

        News & Events

        Multi-million-dollar investment in child health to support vital research

        Four Telethon Kids Institute researchers have received prestigious fellowships and four significant cohort studies led or co-led by Telethon Kids have received key grants under two new funding programs supported by the State Government’s Future Health Research and Innovation (FHRI) Fund. ...

        News and events

        Latest news In the media Researchers from the Rio Tinto Children’s Diabetes Centre, a JDRF Global Centre of Excellence, have been awarded funding ...

        News & Events

        Wal-yan researchers welcomed at scientific meeting in New Zealand

        More than 14 researchers from the Wal-yan Respiratory Research Centre will be welcomed as presenters and facilitators at The Thoracic Society of Australia and New Zealand and The Australia and New Zealand Society of Respiratory Science (TSANZSRS) Annual Scientific Meeting (ASM) this weekend. ...

        Research

        PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life

        Nasopharyngeal colonisation with nontypeable Haemophilus influenzae (NTHi) is associated with development of infections including pneumonia and otitis media. The 10-valent pneumococcal conjugate vaccine (PCV10) uses NTHi Protein D (PD) as a carrier. Papua New Guinean children have exceptionally early and dense NTHi carriage, and high rates of NTHi-associated disease. ...

        Impact: In the Pipeline

        Study offers brighter future for Alex Did you know? New treatments needed Cultural leadership a guiding light Revisiting data for more positive ...

        Research

        The Contribution of Geogenic Particulate Matter to Lung Disease in Indigenous Children

        The aim of this study was to assess the relationship between dust levels and health in Indigenous children in Western Australia ...

        Page 13 of 16